The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2

BACKGROUND: Since the beginning of SARS-CoV2 pandemic, the mortality rate among elderly patients (60–90 years) has been around 50%, so age has been a determining factor of a worse COVID-19 prognosis. Associated with age, the thymic function involution and depletion plays an important role, that coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinar-Buitrago, M. S., Tarancon-Diez, L., Vazquez-Alejo, E., Magro-Lopez, E., Genebat, M., Romero-Candau, F., Leal, M., Muñoz-Fernandez, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320944/
https://www.ncbi.nlm.nih.gov/pubmed/37408063
http://dx.doi.org/10.1186/s12979-023-00351-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320944/
https://www.ncbi.nlm.nih.gov/pubmed/37408063
http://dx.doi.org/10.1186/s12979-023-00351-x

Ejemplares similares